Huma Granted Class II Clearance By FDA For Its Disease-Agnostic Platform

Huma’s platform is now the only remote patient monitoring platform approved in both the US and Europe that is able to aid clinicians in their work.

Huma Therapeutics
• Source: Huma Therapeutics

More from Digital Technologies

More from Medtech Insight